Table 2.
Effects of placebo and plant stanol yoghurt on lipid profile (mean ± SD)a
|
Placebo yoghurt group |
Plant stanol yoghurt group |
pb | |||||
|---|---|---|---|---|---|---|---|
| Baseline | Intervention | Change (%) | Baseline | Intervention | Change (%) | ||
|
Total cholesterol (mg/dl) |
233.4 ± 26.83 |
235.0 ± 23.75 |
1.2 ± 8.11 |
241.1 ± 25.81 |
232.0 ± 22.12 |
−3.4 ± 7.60 |
0.007* |
|
LDL cholesterol (mg/dl) |
154.5 ± 21.16 |
154.1 ± 18.58 |
0.5 ± 10.65 |
157.9 ± 26.40 |
147.7 ± 24.41 |
−5.8 ± 10.90 |
0.005* |
|
HDL cholesterol (mg/dl) |
51.2 ± 11.36 |
50.6 ± 11.62 |
−0.9 ± 10.76 |
50.1 ± 14.35 |
49.6 ± 15.79 |
−1.2 ± 8.87 |
0.524 |
|
Triglycerides (mg/dl) |
138.5 ± 66.41 |
151.6 ± 66.45 |
19.8 ± 53.75 |
165.9 ± 99.42 |
174.0 ± 84.62 |
11.2 ± 27.05 |
0.606 |
|
VLDL cholesterol (mg/dl) |
27.7 ± 13.27 |
30.3 ± 13.26 |
19.8 ± 53.60 |
33.1 ± 19.88 |
34.8 ± 16.92 |
11.3 ± 27.06 |
0.596 |
|
Non-HDL cholesterol (mg/dl) |
182.2 ± 24.54 |
184.4 ± 20.86 |
2.0 ± 12.98 |
191.0 ± 28.24 |
182.5 ± 26.45 |
−4.2 ± 10.73 |
0.005* |
|
Apolipoprotein A-I (mg/dl) |
155.9 ± 20.50 |
154.3 ± 19.28 |
−0.8 ± 6.02 |
152.7 ± 26.12 |
154.4 ± 33.25 |
1.4 ± 13.17 |
0.602 |
|
Apolipoprotein B (mg/dl) |
122.1 ± 19.92 |
121.1 ± 20.28 |
−0.4 ± 8.72 |
128.2 ± 20.09 |
121.0 ± 19.18 |
−5.0 ± 11.81 |
0.076 |
| Lipoprotein-a (mg/dl) | 27.8 ± 26.86 | 29.3 ± 27.78 | 4.1 ± 18.13 | 35.8 ± 31.18 | 32.6 ± 29.39 | −2.8 ± 25.36 | 0.094 |
a :Baseline is Week 0, Intervention is the average of Week 3 and Week 4. Value of Week 2 was used in the calculation of p value, but data was not given at table.
b *p<0.05: Group by time interaction (Repeated measured variance of analysis – general linear model).